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Case report: The case is presented of a 12 year-old boy with congenital glaucoma and low
visual acuity diagnosed with Charles Bonnet syndrome. This consisted of the acute onset
of  complex, repetitive, persistent, and with visual hallucinations (people, brooms and cof-
feemakers) of self-limited evolution without treatment. The patient was diagnosed with
congenital glaucoma at 3 years of age, and subjected to a trabeculectomy in right eye, and
trabeculectomy and keratoplasty in his left eye.
Discussion: Charles Bonnet syndrome symptoms have been described in adults, but their
presence in children is poorly reﬂected in literature, with unknown characteristics and
prevalence.
©  2016 Sociedad Espan˜ola de Oftalmologı´a. Published by Elsevier Espan˜a, S.L.U. All rights
reserved.
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Caso clínico: Presentamos el caso de un nin˜o de 12 an˜os de edad con glaucoma congénito
harles Bonnet y  baja agudeza visual, diagnosticado de síndrome de Charles Bonnet, consistente en alu-
índromelucinaciones
in˜o
cinaciones visuales complejas (personas, escobas y cafeteras), repetitivas, persistentes y
de  aparición brusca, con evolución autolimitada sin tratamiento. El paciente había sido
diagnosticado de glaucoma congénito a los 3 an˜os de edad e intervenido mediante tra-
beculectomía en ojo derecho y trabeculectomía y trasplante de córnea en ojo izquierdo.
 Please cite this article as: Santos-Bueso E, Serrador-García M, Sáenz-Francés F, Méndez-Hernández C, Morales-Fernández L,
artínez-de-la-Casa JM, et al. Síndrome de Charles Bonnet en un nin˜o con glaucoma congénito. Arch Soc Esp Oftalmol. 2017.
ttp://dx.doi.org/10.1016/j.oftal.2016.11.008
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Discusión: El síndrome de Charles Bonnet ha sido descrito en adultos, afecta a más del 15%
de  los pacientes con baja visión, pero su presencia en la edad pediátrica es escasamente
reﬂejada en la literatura, y se desconocen sus características y su prevalencia.
©  2016 Sociedad Espan˜ola de Oftalmologı´a. Publicado por Elsevier Espan˜a, S.L.U. Todos
los derechos reservados.
drome did not produce symptoms such as anxiety or fear asIntroduction
The presence of visual hallucinations in patients is on the
increase in our environment. It is estimated that approxi-
mately 15% of patients with low vision experience an episode
of the Charles Bonnet syndrome1 (CBS). Hallucinations expe-
rienced by patients with poor vision and preserved cognitive
condition, constituting CBS, are very infrequent in the pedi-
atric age and scarcely documented.2,3
The case of a 12-year-old child with congenital glaucoma is
presented, who  exhibited a self-limited CBS during 6 months
which did not require medical treatment.
Clinical  caseMale, 12, who  referred predominantly nocturnal complex
visual hallucinations consisting in visions of unknown peo-
ple who  walked around him without interacting, as well as
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Fig. 1 – Patient campimetry with concentric reduvision of objects (a coffee maker and a broom) in black and
white, which appeared with a frequency of approximately 2–3
times a week. The patient interpreted said visions as unreal
and was aware of his sensory deﬁcit. No relevant familial
history or known allergy was referred. The patient had been
diagnosed with congenital glaucoma at age 3, had undergone
trabeculectomy in both eyes (BE) and subsequently penetrat-
ing keratoplasty in right eye (RE) and Ahmed valve implant in
left eye (LE). Examination produced ﬁnger counting at 1 m in
RE and 20/200 in LE that did not improve with stenopeid hole
in BE and intraocular pressure of 14 mmHg  in BE. OCTOPUS
campimetry was performed (Fig. 1) which showed concentric
defect in RE and nasal step in LE. The patient was examined
at the Neuro-Ophthalmology Unit and diagnosed with CBS. It
was decided not to administer medical treatment as the syn-Time elapsed:
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ction in right eye and nasal step in left eye.
well as because the patient was self-critical of his hallucina-
tions. Six months later, said visual hallucinations disappeared
spontaneously.
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iscussion
he estimated prevalence of visual hallucinations in patients
ith poor vision ranges between 11 and 15%,1 However, stud-
es reported lower prevalence, possibly due to the lack of
nowledge about CBS and the fear of patients to be classi-
ed as psychiatric cases.1,4–6 Most cases have been described
n elderly patients between 75 and 84 years of age, with
light predominance of females, who  exhibited age-related
isual diseases such as macular degeneration, glaucoma or
ataracts. However, CBS has also been described in patients
ith good vision, possibly related to deafferentiation of dam-
ged ﬁbers despite preserving central vision.1,7
A number of theories have been proposed to explain the
rigin of hallucinations. When visual acuity is diminished,
he visual cortex stimulation from the retina is also dimin-
shed without complete disappearance of neuronal activity,
s occurs in amaurosis. This gives rise to what is known as
he deafferentiation process that produces hyper-excitability
f a speciﬁc cortical area in an offsetting effort by the deaf-
erentiated brain area that produces anatomical as well as
iochemical offsetting changes.1,4–7
CBS in pediatric patients is scarcely reported in the liter-
ture. Only 2 studies were found,2,3 excluding the possibility
f establishing a prevalence rate. Mewasingh et al.2 describe
he case of a 9-year-old patient with severe visual impairment
econdary to craniopharyngioma, who exhibited visual hal-
ucinations of animals (zoopsia). Said authors also included
eferences of 3 published cases secondary to cone dystro-
hy and optic nerve glioma.2 Schwartz et al.3 described the
ases of 2 children, 6 and 8 years old, with visual impairment
econdary to cone dystrophy who exhibited hallucinations
onsisting in buildings, human beings and geometrical ﬁgures
patient 1) and vision of colored spheres, human beings and
onsters (patient 2).
In what concerns CBS treatment, there is a large range
f drugs that act at different levels of the central nervous
ystem which must be managed by multidisciplinary depart-
8ents comprising Neurology and Ophthalmology. Due to
he scarcity of statistics there are no guidelines or proto-
ols available. In the case presented herein, hallucinations
ere self-limited and disappeared 6 months later without
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requiring treatment because the patient was critical of them
and his daily life was not disturbed. Mewasingh et al.2 describe
that the patient was treated with carbamazepine due to the
epileptic crises associated to the tumor which diminished the
frequency of hallucinations.
Awareness about CBS, speciﬁcally in pediatric patients,
when its prevalence is signiﬁcantly lower, is important
to develop an adequate differential diagnostic in order to
optimize diagnostic test and treatments, considering the par-
ticular vulnerability of said age group. Both children and their
families would beneﬁt from adequate information about the
Charles Bonnet Syndrome.1,4–8
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